Having trouble viewing this email? View in your browser.
ESCMID Logo

1 November 2016
WEEKLY NEWS

Dear colleagues,

ESCMID Vaccine Study Group EVASG sent out a press release, urging pregnant women to get flu vaccination to protect themselves and their babies.
The first international One Health Day takes place on 3 November. It is dedicated to Jack Woodall (1935 – 2016), a one health leader and co-founder of an early warning system to monitor outbreaks of emerging diseases. One health is at the core of ESCMID's veterinary study group ESGVM, which participates in a number of initiatives including the European Network for Evaluation of One Health.

Best regards, your ESCMID communications editors

 

Nearly 100 applications received for ESCMID research grants

For the 2017 ESCMID research grants we received 97 proposals. We are currently preparing to have the projects reviewed by three reviewers per application. This year ESCMID invited applications for projects on fungal/viral/parasitic infections and diseases (including diagnostics, pathogenesis, susceptibility, resistance, stewardship and vaccines). In addition to the regular EUR 20,000 grants, ESCMID has reserved up to EUR 50,000 each for two excellently rated projects. In the coming newsletters we will highlight the outcomes of some of the research projects funded by ESCMID grants in the past.

› Read more
 

CMI highlight: Airport door handles and global spread of AMR

 A group of German researchers showed that travel through airports does have the potential to introduce antibiotic-resistant bacteria onto surfaces at airports, which may pose a public health risk. International travellers can acquire antimicrobial-resistant bacteria while travelling and spread it in their home countries after returning from abroad. While the study is limited by its small sample size, time delays between sampling and culture and a lack of hygiene information, it also shows that a joint strategy by low, middle and high income countries is required to successfully fight antimicrobial resistance, the authors conclude. ESCMID will send out a press release on the paper 2 November.

› Read more
 

EFISG comments on JAC antifungal stewardship supplement

ESCMID fungal study group comments a Journal of Antimicrobial Chemotherapy supplement on antifungal stewardship. ESCMID Fungal Infection Study Group EFISG welcomes and supports this initiative and takes this opportunity to highlight a few specific recommendations on antifungal stewardship. The series of reviews published in JAC summarize core elements of successful hospital antifungal stewardship programmes and outline how such programmes have been implemented in different clinical settings. Due to the complexity of medical decision-making and the variability in the site and types of care among hospitals worldwide a successful implementation requires flexible models. Read EFISG’s full comments on the study group’s website.

› Read more
 

International conference on infections and prevention in Nanjing

ESCMID is partnering with the International Society for Infectious Diseases (ISID), the Chinese Medical Association and The Lancet Infectious Diseases on the 2nd International Conference on Infections and their Prevention - New Challenges, New Strategies, which takes place in Nanjing, China 18/19 November 2016. Chinese and international speakers will provide updates on severe ID challenges in China, emerging threats, vaccine discovery and implementation and antibiotic therapy and resistance.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.